Our research in ulcerative colitis aimed to develop effective treatments for the gut and give you relief from pain.
Ulcerative Colitis (UC) is a type of Inflammatory Bowel Disease (IBD) characterized by chronic inflammation in the colon and rectum. The diagnosis of UC primarily relies on colonoscopy results. It is more prevalent than Crohn’s disease, occurring three times more frequently. Ulcerative colitis (UC) affects approximately 1 million individuals (about the population of Delaware) in the United States.
Hightower conducted numerous clinical trials to explore potential treatments and research in Ulcerative Colitis. These trials focused on evaluating the safety and effectiveness of new drugs aimed at reducing the symptoms and colon inflammation of patients with moderate to severe UC and IBDIBD.
Not Recruiting
7
M14-533
I6T-MC-AMBI
PN-943-03
VTX002-201
AMUC-2023
M14-234
D5272C00001
M14-675
ABX464-106
Yes, having Inflammatory Bowel Disease (IBD), including conditions like Ulcerative Colitis (UC) and Crohn’s disease, can increase the risk of developing colon cancer over time. However, this risk is generally higher in cases of long-standing and extensive disease involvement.
UC diagnosis typically involves a combination of medical history review, physical examination, blood tests, stool tests, imaging studies (such as colonoscopy or sigmoidoscopy), and biopsy of the colon lining.
You get early access to new treatments, contribute to medical progress, and receive close monitoring by our medical team.
Yes, potential side effects, treatment uncertainty, time commitment, and receiving a placebo are all possibilities.
